Página Inicial (Inglês)
Ensp/ Fiocruz and the Global Health Research Center of the Guangdong University of Foreign Studies in China will sign an agreement to tackle Minamata disease and mercury exposure
Researchers from Brazil - or abroad - can count on the help of Rebec@, the world's first generative artificial intelligence tested and trained to assist in the registration of clinical trials
Coordinate for Fiocruz Amazonia, the research was carried out by scientists from various institutions, national and foreign, and published in the scientific journal 'Frontiers Public Health'
Study from the National Institute of Women, Children and Adolescents Health Fernandes Figueira revealed that human milk contains significant levels of neutralizing antibodies
- Article analyzes the toxic effects of the exposure of pregnant women to pollutants
- Fiocruz to produce API for national manufacture of insulin glargine
- CNPq, Fiocruz and FCT launch call for scientific cooperation between Brazil and Portugal
- WHO and Fiocruz launch Collaborative Open Research Consortium on Flaviviruses
- Mpox: Scientists make progress in understanding the virus
- Fiocruz signs four cooperation agreements during Brazil-Portugal Summit
- Research links extreme heat to mortality in Rio de Janeiro
- French Ambassador visits Fiocruz to expand cooperation
- New study points to inequalities in access to hospital births in Brazil
- Fiocruz works to develop an unprecedented test for diagnosing acute diarrhea
- Article: Gender inequality in science is bad for health
- Executive director of the Pasteur Network discusses greater participation by Fiocruz
- Tuberculosis: research estimates that Brazil will not meet WHO targets by 2030
- Fiocruz leads CORC on Flaviviruses and begins internal mapping
- Oropouche: Fiocruz and PAHO prepare manual for entomologists in the Americas
- Fiocruz participates in the Launch of the 100 Days Mission Report in Africa
Subscribe to Fiocruz International Newsletter
Subscribe and receive our news via email
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
